TER-1754

TER-1754 · Terremoto Biosciences Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TER-1754, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia [Phase 1]